Upper Respiratory Tract Levels of Severe Acute Respiratory Syndrome Coronavirus 2 RNA and Duration of Viral RNA Shedding Do Not Differ Between Patients With Mild and Severe/Critical Coronavirus Disease 2019 yilmaz2020upper

The authors reported longitudinal viral RNA loads from the nasopharynx/oropharynx in patients with mild and severe/critical coronavirus disease 2019 (COVID-19). They also investigated whether the duration of symptoms correlated with the duration of viral RNA shedding. A total of 56 patients were included.

Analytes

oropharyngealswab_SARSCoV2

The author collected serial upper respiratory tract samples (one nasopharyngeal swab and one oropharyngeal swab were put in a single collection tube with 1 mL of transport medium) for real-time PCR of SARS-CoV-2 RNA for all patients.

exponential for oropharyngealswab_SARSCoV2

Fitted by censored maximum likelihood. The red line is the median individual; the shaded region is the full range of a simulated cohort drawn from the fitted population, so it shows what simulating from this dataset would produce rather than a confidence interval, with dashed lines at the central 95%. Open triangles are non-detects, drawn at the censoring limit and entering the fit as "below this value" rather than being dropped. See the modelling methods for what these estimates do and do not support.

Biomarker: SARS-CoV-2
Specimen: nasopharyngeal swab and oropharyngeal swab
Units: cycle threshold
Gene target: RdRp
Participants: 54
Negative samples: 80
Positive samples (not quantifiable): 0
Quantifiable samples: 269
Limit of quantification: unknown
Limit of detection: 40